These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9291436)

  • 21. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
    Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
    Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression of CD44 splice variants in malignant and benign pleural effusions.
    Tojo N; Inase N; Ichioka M; Miyazato I; Nara N
    Tohoku J Exp Med; 1996 Aug; 179(4):273-9. PubMed ID: 8944429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
    Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
    Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD44 molecules in serum of patients with prostate cancer and benign prostatic hyperplasia.
    Jung K; Lein M; Weiss S; Schnorr D; Henke W; Loening S
    Eur J Cancer; 1996 Apr; 32A(4):627-30. PubMed ID: 8695265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
    Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD44 variants in osteosarcoma.
    Kuryu M; Ozaki T; Nishida K; Shibahara M; Kawai A; Inoue H
    J Cancer Res Clin Oncol; 1999 Nov; 125(11):646-52. PubMed ID: 10541973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum CD44 levels and overall survival in patients with HER2-positive breast cancer.
    Baek JM; Jin Q; Ensor J; Boulbes DR; Esteva FJ
    Breast Cancer Res Treat; 2011 Dec; 130(3):1029-36. PubMed ID: 21830016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble CD44 variants in the serum of patients with urological malignancies.
    Lein M; Jung K; Weiss S; Schnorr D; Loening SA
    Oncology; 1997; 54(3):226-30. PubMed ID: 9143404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CD44 splice variants in human primary brain tumors.
    Kaaijk P; Troost D; Morsink F; Keehnen RM; Leenstra S; Bosch DA; Pals ST
    J Neurooncol; 1995 Dec; 26(3):185-90. PubMed ID: 8750184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
    Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
    Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines.
    Stickeler E; Runnebaum IB; Möbus VJ; Kieback DG; Kreienberg R
    Anticancer Res; 1997; 17(3C):1871-6. PubMed ID: 9216637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CD44 splice variants as prognostic factors in invasive cervix carcinoma].
    Reinthaller A; Kainz C; Kohlberger P; Tempfer C; Gitsch G; Kölbl H; Breitenecker G
    Gynakol Geburtshilfliche Rundsch; 1995; 35(1):16-9. PubMed ID: 7537136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the prognostic value of serum soluble CD 44 in patients with breast cancer.
    Sheen-Chen SM; Chen WJ; Eng HL; Sheen CC; Chou FF; Cheng YF
    Cancer Invest; 1999; 17(8):581-5. PubMed ID: 10592765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Schwann cell tumors express characteristic patterns of CD44 splice variants.
    Sherman L; Skroch-Angel P; Moll J; Schwechheimer K; Ponta H; Herrlich P; Hofmann M
    J Neurooncol; 1995 Dec; 26(3):171-84. PubMed ID: 8750183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of CD44 variants and its association with survival in pancreatic cancer.
    Gotoda T; Matsumura Y; Kondo H; Saitoh D; Shimada Y; Kosuge T; Kanai Y; Kakizoe T
    Jpn J Cancer Res; 1998 Oct; 89(10):1033-40. PubMed ID: 9849582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of angiogenesis, laminin and CD44 expression in metastatic behavior of early-stage low-grade invasive breast carcinomas.
    Ozer E; Canda T; Kurtodlu B
    Cancer Lett; 1997 Dec; 121(2):119-23. PubMed ID: 9570348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serological evaluation of soluble CD44 in renal cancer.
    Kan M; Kanayama H; Naruo S; Tsuji M; Kojima K; Kurokawa Y; Kagawa S
    Jpn J Cancer Res; 1996 Nov; 87(11):1191-4. PubMed ID: 9045950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD44 exon 6 expression as a possible early prognostic factor in primary node negative breast carcinoma.
    Guriec N; Marcellin L; Gairard B; Caldéroli H; Wilk A; Renaud R; Bergerat JP; Oberling F
    Clin Exp Metastasis; 1996 Oct; 14(5):434-9. PubMed ID: 8871537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patients.
    Kittl EM; Ruckser R; Selleny S; Samek V; Hofmann J; Huber K; Reiner A; Ogris E; Hinterberger W; Bauer K
    Exp Clin Immunogenet; 1997; 14(4):264-72. PubMed ID: 9523162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.